CEBPB and glioma: Activated NF-κB can mediate the activation of STAT3, CEBPB, and TAZ by upregulating the expression of CD44, vimentin, and N-cadherin, thereby promoting the invasion, angiogenesis, and therapeutic resistance of glioma [3, 43–45].